Feider Stephen 4
4 · Beta Bionics, Inc. · Filed Sep 9, 2025
Insider Transaction Report
Form 4
Feider Stephen
Chief Financial Officer
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2025-09-08−9,900→ 89,695 totalExercise: $5.10Exp: 2033-09-13→ Common Stock (9,900 underlying) - Sale
Common Stock
2025-09-08$21.13/sh−9,900$209,151→ 44,041 total - Exercise/Conversion
Common Stock
2025-09-08$5.10/sh+9,900$50,490→ 53,941 total
Footnotes (3)
- [F1]Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025.
- [F2]The weighted average sale price for the transaction reported was $21.126480 and the range of prices were between $21.00 and $21.2933. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F3]The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023.